The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab–Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center

Autor: Al-Obaidi, Mohanad M., Gungor, Ahmet B., Kurtin, Sandra E., Mathias, Ann E., Tanriover, Bekir, Zangeneh, Tirdad T.
Zdroj: In The American Journal of Medicine January 2023 136(1):96-99
Databáze: ScienceDirect